Inhibitors of Rhomboid Intramembrane Proteases

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F20%3A00536421" target="_blank" >RIV/61388963:_____/20:00536421 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20200923&DB=&locale=en_EP&CC=GB&NR=2563396B&KC=B&ND=4" target="_blank" >https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20200923&DB=&locale=en_EP&CC=GB&NR=2563396B&KC=B&ND=4</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Inhibitors of Rhomboid Intramembrane Proteases
Original language description
A compound of formula (I) or a pharmaceutically acceptable salt, ester or pro-drug thereof: wherein R1 is a substituent, R2 and R5 are hydrogen or alkyl, R3 and R4 are hydrogen or a substituent, or, taken together with the atoms to which they are attached, R1 and R2 or R1 and R3 form a heterocyclyl ring, R6 and R7 are hydrogen or a substituent, or, taken together with the carbon atom to which they are attached, R6 and R7 form a cycloalkyl or heterocyclyl ring, W represents (Aaa)n, wherein each Aaa is an independently selected amino acid, n is an integer of from 1 to 20. These compounds are inhibitors of rhomboid intramembrane proteases based on peptidyl ketoamides. The compounds, and pharmaceutical compositions containing them, can be used for the use in the treatment of e.g. malaria, Parkinsons disease, cancer, diabetes and bacterial infections.
Czech name
—
Czech description
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)